THERAPY WITH ORALLY-ADMINISTERED METHOXSALEN AND ULTRAVIOLET-A RADIATION DURING CHILDHOOD INCREASES THE RISK OF BASAL-CELL CARCINOMA

Authors
STERN RS NICHOLS KT BAUER C KOO J EPSTEIN JH WOLF J NIGRA TP VOORHEES J ANDERSON TF PRYSTOWSKY J MULLER S MCEVOY M TAYLOR JR ZAIAS N URBACH F ARNDT KA BAUGHMAN RD BRAVERMAN IM MURRAY J WERTH V SOBER A
Citation
Rs. Stern et al., THERAPY WITH ORALLY-ADMINISTERED METHOXSALEN AND ULTRAVIOLET-A RADIATION DURING CHILDHOOD INCREASES THE RISK OF BASAL-CELL CARCINOMA, The Journal of pediatrics, 129(6), 1996, pp. 915-917
Citations number
8
Categorie Soggetti
Pediatrics
Journal title
The Journal of pediatrics → ACNP
ISSN journal
00223476
Volume
129
Issue
6
Year of publication
1996
Pages
915 - 917
Database
ISI
SICI code
0022-3476(1996)129:6<915:TWOMAU>2.0.ZU;2-R
Abstract
A child was treated from age 18 months to 8 years with oral methoxsale n and ultraviolet A radiation (PUVA) for refractory psoriasis. Two bas al cell cancers developed before age 21 years, suggesting that exposur e to PUVA in childhood increases the risk of basal cell cancer.